We investigated differences in outcomes between 68 children hospitalized with macrolide-sensitive Mycoplasma pneumoniae pneumonia (MSMP group) and 25 children hospitalized with macrolide-resistant M. pneumoniae pneumonia (MRMP group). In the MRMP group, 19 children received macrolides and clinical failure occurred in six of which five had pneumonia progression during therapy.
No takes yet. Share an insight, caveat, or question.
Cheong et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: